ResearcherFirst Affiliated Hospital of Nanchang UniversityActive in the last 2 years

Liang Zhu

ORCID-verified (high confidence)As of 10 November 2026

Matched on ORCID iD 0009-0002-7871-9712; OpenAlex author ID A5107413219.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Collaborators: 2

Papers, trials and grants by year

2024: 1 paper

Papers 1

Metformin Inhibits the Progression of Pancreatic Cancer Through Regulating miR-378a-3p/VEGFA/RGC-32 Axis. Last author DOI 10.1002/cam4.70446 ↗

Closest collaborators

The 2 strongest of 2 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Ying Ding · 1 shared paper, 2024
- Paper Metformin Inhibits the Progression of Pancreatic Cancer Through Regulating miR-378a-3p/VEGFA/RGC-32 Axis. DOI 10.1002/cam4.70446 ↗
Jinli He · 1 shared paper, 2024
- Paper Metformin Inhibits the Progression of Pancreatic Cancer Through Regulating miR-378a-3p/VEGFA/RGC-32 Axis. DOI 10.1002/cam4.70446 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.